ABSTRACT
Introduction: Osteoporotic vertebral fractures that produce increased morbidity, persistent back pain, risk of collapse with time, and increased fracture risk. Subsequently, these vertebral fractures produce kyphotic deformity and effect on lung capacity. In our study purpose is to assess the clinical outcome, safety, and efficacy of transpedicular percutaneous vertebroplasty in osteoporotic vertebral compression fractures (VCFs). Methodology: The study done between December 2017 and December 2019 at our institute. Atotal of 10 patients with 21 vertebral body collapse in that 13 dorsal vertebra and 8 lumbar vertebral body included in the study in neurologically intact individuals. Patients are considered for treatment, those with chronic pain refractory to medical therapy and bracing and those with severe disabling pain caused by fractures. Severe cardiopulmonary disease, coagulopathy, and cord compression are contraindications to vertebroplasty. Severe vertebral compression may also be a contraindication to treatment, because the vertebra may be compressed to such a degree that needle placement and cement injection become impossible. After treatment, they selected one of three possible responses for each: Significantly improved, worse, or approximately the same. As an overall assessment analgesic requirement, visual analog scale, grading of subjective satisfaction score, sleep, and ambulation improvement assessed. To ensure uniformity despite the variable follow-up period, patients were instructed to indicate their status at 2 weeks after the procedure, 6 months, and 1-year follow-up. Results: Both pain and functional outcome improved significantly in immediate post-procedure at 2 weeks, 6 months, and 1 year. The majority (70%) of the patients were treated for 2 levels while 2 patients were treated for 3 levels and 1 patient was treated for 1 level. Visual analog scale (VAS) in the pre-procedure period is 8.3 which decrease in the post-procedure period at 2 weeks and 6 months is 2.6 and 3.6 subsequently and at 1-year average VAS score is 4. Mobility and sleep pattern is significantly improved in 8 patients (80%) at 1-year follow-up whereas remain same in 2 patients. Conclusion: Significant relief in pain in the post-procedure period with minimum risk noticed for VCFs.